WOOJUNG BIO Inc (215380) — Capital Reinvestment Ratio
Latest as of March 2025:
0.12x
WOOJUNG BIO Inc (215380) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩191.51 Million). See WOOJUNG BIO Inc (215380) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.59 Billion
KRW
Capital Expenditures
₩191.51 Million
KRW
Data as of
Mar 2025
Most recent filing
WOOJUNG BIO Inc Capital Reinvestment Ratio (2019–2022)
This chart tracks WOOJUNG BIO Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for WOOJUNG BIO Inc (2019–2022)
Year-by-year Capital Reinvestment Ratio for WOOJUNG BIO Inc from 2019 to 2022. For live market cap and broader valuation context, see market cap of WOOJUNG BIO Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 4.56x | ₩2.50 Billion | ₩11.42 Billion | ▼ -78.5% |
| 2021 | 21.23x | ₩1.73 Billion | ₩36.68 Billion | ▲ +105.0% |
| 2019 | 10.36x | ₩208.72 Million | ₩2.16 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow